Prevention of human immunodeficiency virus breastmilk transmission with copper oxide: Proof-of-concept study

Breastfeeding Medicine

Volumn 6, Issue 4, 2011, Pages 165-170

  Borkow, Gadi ^a   Covington, Chandice Y ^b   Gautam, Bibha ^b   Anzala, Omu ^c   Oyugi, Julius ^c   Juma, Meshack ^c   Abdullah, Mohamed S ^d  

^a Cupron Scientific   (Israel)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d AGA KHAN UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ION; COPPER OXIDE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE;

ARTICLE; BREAST MILK; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; STOICHIOMETRY; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

BREAST FEEDING; COPPER; DEVELOPING COUNTRIES; EQUIPMENT DESIGN; FEMALE; FILTRATION; HIV INFECTIONS; HIV PROTEASE; HIV-1; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MILK, HUMAN; POWDERS; TRACE ELEMENTS; TREATMENT OUTCOME; VIRUS INACTIVATION; VIRUS REPLICATION;

EID: 79960659013     PISSN: 15568253     EISSN: 15568342     Source Type: Journal    
DOI: 10.1089/bfm.2010.0090     Document Type: Article

References (39)

1. Kourtis AP, Butera S, Ibegbu C, et al. Breast milk and HIV-1: Vector of transmission or vehicle of protection? Lancet Infect Dis 2003;3:786-793. (Pubitemid 37489962)
2. Kourtis AP, Lee FK, Abrams EJ, et al. Mother-to-child transmission of HIV-1: Timing and implications for prevention. Lancet Infect Dis 2006;6:726-732. (Pubitemid 44601992)
3. Joint United Nations Programme on HIV/AIDS. UNAIDS Report on the Global Aids Epidemic, 2010. www.unaids http://www.unaids .org/documents/20101123- GlobalReport-em.pdf (accessed February 22, 2011).
4. Lawrence RA, Lawrence RM. Breastfeeding: A Guide for the Medical Profession, 7th ed. Elsevier Mosby, Missouri Heights, MO, 2011, p. 20.
5. Fawzi W, Msamanga G, Spiegelman D, et al. Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 2002;31: 331-338. (Pubitemid 35278635)
6. Miotti PG, Taha TE, Kumwenda NI, et al. HIV transmission through breastfeeding: A study in Malawi. JAMA 1999;282: 744-749. (Pubitemid 29404380)
7. Nduati R, Richardson BA, John G, et al. Effect of breastfeeding on mortality among HIV-1 infected women: A randomized trial. Lancet 2001;357:1651-1655. (Pubitemid 32568238)
8. Torpey K, Kasonde P, Kabaso M, et al. Reducing pediatric HIV infection: Estimating mother-to-child transmission rates in a program setting in Zambia. J Acquir Immune Defic Syndr 2010;54:415-422.
9. Walter J, Kuhn L, Aldrovandi GM. Advances in basic science understanding of mother-to-child HIV-1 transmission. Curr Opin HIV AIDS 2008;3:146-150. (Pubitemid 351322828)
10. World Health Organization. Guidelines on HIV and Infant Feeding 2010: Principles and Recommendations for Infant Feeding in the Context of HIV and a Summary of Evidence. 2011, p. 6. www.waba.org.my/pdf/WHOHIV idelines2010 .pdf (accessed February 17, 2011).
11. Hamosh M. Bioactive factors in human milk. Pediatr Clin North Am 2001;48:69-86. (Pubitemid 32193128)
12. Lawrence RM, Lawrence RA. Breast milk and infection. Clin Perinatol 2004;31:501-528. (Pubitemid 39119482)
13. World Health Organization. Acceptable Medical Reasons for Use of Breast-Milk Substitutes 2009. whqlibdoc.who.int/hq/ 2009/WHO-FCH-CAH-09.01-eng. pdf (accessed February 10, 2011).
14. Block SS. Definition in terms. Disinfection Sterilisation Preservation 2001;9:1857.
15. Borkow G, Gabbay J. An ancient remedy returning to fight microbial, fungal and viral infections. Curr Chem Biol 2009; 3:272-278.
16. Borkow G, Gabbay J. Copper as a biocidal tool. Curr Med Chem 2005;12:2163-2175. (Pubitemid 41086750)
17. Sagripanti JL, Lightfoote MM. Cupric and ferric ions inactivate HIV. AIDS Res Hum Retroviruses 1996;12:333-337.
18. Karlstrom AR, Levine RL. Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms. Proc Natl Acad Sci U S A 1991;88:5552-5556. (Pubitemid 21914783)
19. Borkow G, Sidwell RW, Smee DF, et al. Neutralizing viruses in suspensions by copper oxide based filters. Antimicrob Agents Chemother 2007;51:2605-2607. (Pubitemid 47047346)
20. Borkow G, Lara HH, Covington CY, et al. Deactivation of human immunodeficiency virus type 1 in medium by copper oxide-containing filters. Antimicrob Agents Chemother 2008; 52:518-525. (Pubitemid 351170823)
21. Nicholls D. Complexes and First-Row Transition Elements. Macmillan Press, London, 1973.
22. Lutsenko S. Human copper homeostasis: A network of interconnected pathways. Curr Opin Chem Biol 2010;14: 211-217.
23. Trumbo P, Yates AA, Schlicker S, et al. Dietary reference intakes: Vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc 2001;101:294-301.
24. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938;27:493-497.
25. Chackerian B, Long EM, Luciw PA, et al. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol 1997;71: 3932-3939. (Pubitemid 27172408)
26. Kimpton J, Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol 1992;66:2232-2239.
27. Richardson BA, Hughes JP. Modeling breastmilk infectivity in HIV-1 infected mothers. Biometrics 2003;59:179-185. (Pubitemid 36523121)
28. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: A randomized clinical trial. JAMA 2000;283:1167-1174. (Pubitemid 30126605)
29. Leroy V, Montcho C, Manigart O, et al. Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial. AIDS 2001;15: 517-522. (Pubitemid 32207572)
30. Taha TE, Kumwenda NI, Hoover DR, et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: A randomized controlled trial. JAMA 2004;292:202-209. (Pubitemid 38917997)
31. Chasela CS, Hudgens MG, Jamieson DJ, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010;362:2271-2281.
32. Phillips AN, Lampe FC, Smith CJ, et al. Ongoing changes in HIV RNA levels during untreated HIV infection: Implications for CD4 cell count depletion. AIDS 2010;24: 1561-1567.
33. Becquet R, Bland R, Leroy V, et al. Duration, pattern of breastfeeding and postnatal transmission of HIV: Pooled analysis of individual data from West and South African cohorts. PLoS One 2009;4:e7397.
34. Taha TE. Mother-to-child transmission of HIV-1 in sub- Saharan Africa: Past, present and future challenges. Life Sci 2011;88:917-921.
35. Rosen S, Sanne I, Collier A, et al. Rationing antiretroviral therapy for HIV/AIDS in Africa: Choices and consequences. PLoS Med 2005;2:e303.
36. WHO, UNICEF, UNAIDS. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. 2010. whqlibdoc.who.int/ publications/2010/ 9789241500395-eng.pdf (accessed May 15, 2011).
37. Hirnschall G, Schwartlander B. Treatment 2.0: Catalysing the next phase of scale-up. Lancet 2011; Epub ahead of print, p. 1. DOI: 10.1016/S0140-6736(11) 60247-X.
38. McKechnie AC, Eglash A. Nipple shields: A review of the literature. Breastfeed Med 2010;5:309-314.
39. Kaye R, Crowley J. Medical Device Use-Safety: Incorporating Human Factors Engineering into Risk Management Identifying, Understanding, and Addressing Use-Related Hazards. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Division of Device User Programs and Systems Analysis, Office of Health and Industry Programs. July 18, 2000. www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/ GuidanceDocuments/ cm094460.htm (accessed June 2011).